4//SEC Filing
Levine James E. 4
Accession 0001628280-23-008356
CIK 0001213037other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 5:42 PM ET
Size
5.6 KB
Accession
0001628280-23-008356
Insider Transaction Report
Form 4
Levine James E.
Chief Financial Officer
Transactions
- Award
Stock Options
2023-03-15+197,472→ 757,488 totalExercise: $1.72Exp: 2033-03-15→ Common Stock (197,472 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option will vest on March 15, 2024 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the continued service of the reporting person.
Documents
Issuer
Cardiff Oncology, Inc.
CIK 0001213037
Entity typeother
Related Parties
1- filerCIK 0001463151
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 5:42 PM ET
- Size
- 5.6 KB